Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Upgrades
Ladenburg Thalmann upgraded the previous rating for Edison International (NYSE:EIX) from Sell to Neutral. Edison Intl earned $1.01 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $74.92 and a 52-week-low of $54.51. At the end of the last trading period, Edison Intl closed at $69.76.
For Hannon Armstrong Sustainable Infrastructure Capital Inc (NYSE:HASI), B of A Securities upgraded the previous rating of Neutral to Buy. Hannon Armstrong earned $0.53 in the second quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $44.41 and a 52-week-low of $21.31. Hannon Armstrong closed at $23.12 at the end of the last trading period.
Janney Montgomery Scott upgraded the previous rating for Shore Bancshares Inc (NASDAQ:SHBI) from Neutral to Buy. For the second quarter, Shore Bancshares had an EPS of $0.25, compared to year-ago quarter EPS of $0.39. The current stock performance of Shore Bancshares shows a 52-week-high of $20.49 and a 52-week-low of $10.65. Moreover, at the end of the last trading period, the closing price was at $11.39.
Oppenheimer upgraded the previous rating for Redfin Corp (NASDAQ:RDFN) from Underperform to Perform. Redfin earned $0.25 in the second quarter, compared to $0.73 in the year-ago quarter. The stock has a 52-week-high of $17.68 and a 52-week-low of $3.08. At the end of the last trading period, Redfin closed at $10.16.
According to Raymond James, the prior rating for CareDx Inc (NASDAQ:CDNA) was changed from Market Perform to Outperform. CareDx earned $0.18 in the second quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.54 and a 52-week-low of $6.22. CareDx closed at $9.35 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Pharvaris NV (NASDAQ:PHVS) was changed from Equal-Weight to Overweight. Pharvaris earned $0.69 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $21.71 and a 52-week-low of $1.80. At the end of the last trading period, Pharvaris closed at $18.42.
RBC Capital upgraded the previous rating for Hexcel Corp (NYSE:HXL) from Sector Perform to Outperform. In the second quarter, Hexcel showed an EPS of $0.50, compared to $0.33 from the year-ago quarter. The current stock performance of Hexcel shows a 52-week-high of $79.08 and a 52-week-low of $50.25. Moreover, at the end of the last trading period, the closing price was at $69.11.
For NextDecade Corp (NASDAQ:NEXT), Stifel upgraded the previous rating of Hold to Buy. NextDecade earned $0.23 in the first quarter, compared to $0.14 in the year-ago quarter. The current stock performance of NextDecade shows a 52-week-high of $8.94 and a 52-week-low of $3.92. Moreover, at the end of the last trading period, the closing price was at $5.53.
See all analyst ratings upgrades.
Downgrades
According to Laidlaw & Co., the prior rating for Alaunos Therapeutics Inc (NASDAQ:TCRT) was changed from Buy to Hold. In the second quarter, Alaunos Therapeutics showed an EPS of $0.04, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.01 and a 52-week-low of $0.38. Alaunos Therapeutics closed at $0.39 at the end of the last trading period.
According to SVB Leerink, the prior rating for Galecto Inc (NASDAQ:GLTO) was changed from Outperform to Market Perform. Galecto earned $0.41 in the second quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $3.70 and a 52-week-low of $1.06. At the end of the last trading period, Galecto closed at $2.34.
For Chicken Soup for the Soul Entertainment Inc (NASDAQ:CSSE), Craig-Hallum downgraded the previous rating of Buy to Hold. For the second quarter, Chicken Soup for the Soul had an EPS of $1.50, compared to year-ago quarter EPS of $1.28. The stock has a 52-week-high of $13.44 and a 52-week-low of $0.94. At the end of the last trading period, Chicken Soup for the Soul closed at $1.01.
For Design Therapeutics Inc (NASDAQ:DSGN), Wedbush downgraded the previous rating of Outperform to Neutral. Design Therapeutics earned $0.36 in the second quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $26.30 and a 52-week-low of $4.90. At the end of the last trading period, Design Therapeutics closed at $7.33.
According to Alliance Global Partners, the prior rating for Chicken Soup for the Soul Entertainment Inc (NASDAQ:CSSE) was changed from Buy to Neutral. Chicken Soup for the Soul earned $1.50 in the second quarter, compared to $1.28 in the year-ago quarter. The stock has a 52-week-high of $13.44 and a 52-week-low of $0.94. At the end of the last trading period, Chicken Soup for the Soul closed at $1.01.
Mizuho downgraded the previous rating for BioXcel Therapeutics Inc (NASDAQ:BTAI) from Buy to Neutral. For the second quarter, BioXcel Therapeutics had an EPS of $1.83, compared to year-ago quarter EPS of $1.35. The current stock performance of BioXcel Therapeutics shows a 52-week-high of $34.12 and a 52-week-low of $3.81. Moreover, at the end of the last trading period, the closing price was at $4.33.
According to Citigroup, the prior rating for Gol Intelligent Airlines Inc (NYSE:GOL) was changed from Buy to Neutral. In the second quarter, Gol Intelligent Airlines showed an EPS of $0.48, compared to $0.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.59 and a 52-week-low of $2.00. Gol Intelligent Airlines closed at $3.71 at the end of the last trading period.
For Design Therapeutics Inc (NASDAQ:DSGN), SVB Leerink downgraded the previous rating of Outperform to Market Perform. For the second quarter, Design Therapeutics had an EPS of $0.36, compared to year-ago quarter EPS of $0.27. The current stock performance of Design Therapeutics shows a 52-week-high of $26.30 and a 52-week-low of $4.90. Moreover, at the end of the last trading period, the closing price was at $7.33.
According to B of A Securities, the prior rating for Valero Energy Corp (NYSE:VLO) was changed from Buy to Neutral. Valero Energy earned $5.40 in the second quarter, compared to $11.36 in the year-ago quarter. The stock has a 52-week-high of $160.16 and a 52-week-low of $97.76. At the end of the last trading period, Valero Energy closed at $136.50.
For PBF Energy Inc (NYSE:PBF), B of A Securities downgraded the previous rating of Buy to Neutral. For the second quarter, PBF Energy had an EPS of $2.29, compared to year-ago quarter EPS of $10.58. The stock has a 52-week-high of $50.43 and a 52-week-low of $27.02. At the end of the last trading period, PBF Energy closed at $49.52.
According to B of A Securities, the prior rating for Marathon Petroleum Corp (NYSE:MPC) was changed from Buy to Neutral. Marathon Petroleum earned $5.32 in the second quarter, compared to $10.61 in the year-ago quarter. The stock has a 52-week-high of $149.76 and a 52-week-low of $89.41. At the end of the last trading period, Marathon Petroleum closed at $148.54.
According to B of A Securities, the prior rating for HF Sinclair Corp (NYSE:DINO) was changed from Buy to Neutral. For the second quarter, HF Sinclair had an EPS of $2.60, compared to year-ago quarter EPS of $5.59. The current stock performance of HF Sinclair shows a 52-week-high of $66.17 and a 52-week-low of $37.12. Moreover, at the end of the last trading period, the closing price was at $57.95.
According to RBC Capital, the prior rating for Design Therapeutics Inc (NASDAQ:DSGN) was changed from Outperform to Sector Perform. In the second quarter, Design Therapeutics showed an EPS of $0.36, compared to $0.27 from the year-ago quarter. The current stock performance of Design Therapeutics shows a 52-week-high of $26.30 and a 52-week-low of $4.90. Moreover, at the end of the last trading period, the closing price was at $7.33.
HC Wainwright & Co. downgraded the previous rating for Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) from Buy to Neutral. For the first quarter, Zynerba Pharmaceuticals had an EPS of $0.21, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $1.38 and a 52-week-low of $0.25. At the end of the last trading period, Zynerba Pharmaceuticals closed at $1.35.
For 22nd Century Group Inc (NASDAQ:XXII), TD Cowen downgraded the previous rating of Outperform to Market Perform. 22nd Century Group earned $1.40 in the second quarter, compared to $0.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.82 and a 52-week-low of $2.10. 22nd Century Group closed at $2.29 at the end of the last trading period.
According to Citigroup, the prior rating for Agiliti Inc (NYSE:AGTI) was changed from Buy to Neutral. For the second quarter, Agiliti had an EPS of $0.14, compared to year-ago quarter EPS of $0.19. The current stock performance of Agiliti shows a 52-week-high of $20.11 and a 52-week-low of $10.76. Moreover, at the end of the last trading period, the closing price was at $11.71.
For Forward Air Corp (NASDAQ:FWRD), Baird downgraded the previous rating of Outperform to Neutral. In the second quarter, Forward Air showed an EPS of $0.91, compared to $2.04 from the year-ago quarter. The current stock performance of Forward Air shows a 52-week-high of $121.38 and a 52-week-low of $72.16. Moreover, at the end of the last trading period, the closing price was at $73.23.
Truist Securities downgraded the previous rating for Avid Technology Inc (NASDAQ:AVID) from Buy to Hold. In the second quarter, Avid Technology showed an EPS of $0.22, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $33.41 and a 52-week-low of $19.78. At the end of the last trading period, Avid Technology closed at $26.60.
For Pennant Park Investment Corp (NYSE:PNNT), Compass Point downgraded the previous rating of Buy to Neutral. For the third quarter, Pennant Park Investment had an EPS of $0.35, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $7.07 and a 52-week-low of $4.70. At the end of the last trading period, Pennant Park Investment closed at $6.82.
See all analyst ratings downgrades.
Initiations
Loop Capital initiated coverage on Savers Value Village Inc (NYSE:SVV) with a Buy rating. The price target for Savers Value Village is set to $31.00. In the second quarter, Savers Value Village showed an EPS of $0.22, compared to $0.26 from the year-ago quarter. The current stock performance of Savers Value Village shows a 52-week-high of $26.43 and a 52-week-low of $21.50. Moreover, at the end of the last trading period, the closing price was at $25.70.
With a Buy rating, B of A Securities initiated coverage on Turnstone Biologics Corp (NASDAQ:TSBX). The price target seems to have been set at $18.00 for Turnstone Biologics. The current stock performance of Turnstone Biologics shows a 52-week-high of $13.20 and a 52-week-low of $10.11. Moreover, at the end of the last trading period, the closing price was at $11.73.
SVB Leerink initiated coverage on Cytokinetics Inc (NASDAQ:CYTK) with an Outperform rating. The price target for Cytokinetics is set to $58.00. For the second quarter, Cytokinetics had an EPS of $1.34, compared to year-ago quarter EPS of $0.23. The current stock performance of Cytokinetics shows a 52-week-high of $55.79 and a 52-week-low of $30.66. Moreover, at the end of the last trading period, the closing price was at $32.10.
Cantor Fitzgerald initiated coverage on Computer Programs and Systems Inc (NASDAQ:CPSI) with an Overweight rating. The price target for CPSI is set to $24.00. For the second quarter, CPSI had an EPS of $0.40, compared to year-ago quarter EPS of $0.59. At the moment, the stock has a 52-week-high of $32.86 and a 52-week-low of $19.99. CPSI closed at $20.10 at the end of the last trading period.
With an Overweight rating, Cantor Fitzgerald initiated coverage on R1 RCM Inc (NASDAQ:RCM). The price target seems to have been set at $20.00 for R1 RCM. For the second quarter, R1 RCM had an EPS of $0.00, compared to year-ago quarter EPS of $0.07. The current stock performance of R1 RCM shows a 52-week-high of $26.44 and a 52-week-low of $6.71. Moreover, at the end of the last trading period, the closing price was at $16.80.
With an Overweight rating, Piper Sandler initiated coverage on Turnstone Biologics Corp (NASDAQ:TSBX). The price target seems to have been set at $20.00 for Turnstone Biologics. At the moment, the stock has a 52-week-high of $13.20 and a 52-week-low of $10.11. Turnstone Biologics closed at $11.73 at the end of the last trading period.
With a Buy rating, Roth MKM initiated coverage on New Found Gold Corp (AMEX:NFGC). The price target seems to have been set at $9.00 for New Found Gold. For the first quarter, New Found Gold had an EPS of $0.08, compared to year-ago quarter EPS of $0.14. The current stock performance of New Found Gold shows a 52-week-high of $5.70 and a 52-week-low of $2.93. Moreover, at the end of the last trading period, the closing price was at $4.47.
Barclays initiated coverage on ODDITY Tech Ltd (NASDAQ:ODD) with an Overweight rating. The price target for ODDITY Tech is set to $57.00. In the second quarter, ODDITY Tech showed an EPS of $0.56, compared to $0.33 from the year-ago quarter. The stock has a 52-week-high of $56.00 and a 52-week-low of $45.66. At the end of the last trading period, ODDITY Tech closed at $46.35.
JP Morgan initiated coverage on Frontline Plc (NYSE:FRO) with a Neutral rating. The price target for Frontline is set to $20.00. In the first quarter, Frontline showed an EPS of $0.87, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $19.29 and a 52-week-low of $10.11. At the end of the last trading period, Frontline closed at $17.66.
JP Morgan initiated coverage on Euronav NV (NYSE:EURN) with an Overweight rating. The price target for Euronav is set to $21.50. At the moment, the stock has a 52-week-high of $21.00 and a 52-week-low of $12.94. Euronav closed at $17.63 at the end of the last trading period.
Oppenheimer initiated coverage on Knife River Holding Co (NYSE:KNF) with an Outperform rating. The price target for Knife River Holding is set to $65.00. Knife River Holding earned $1.00 in the second quarter, compared to $0.68 in the year-ago quarter. The stock has a 52-week-high of $52.40 and a 52-week-low of $33.67. At the end of the last trading period, Knife River Holding closed at $50.55.
With an Overweight rating, Keybanc initiated coverage on ODDITY Tech Ltd (NASDAQ:ODD). The price target seems to have been set at $60.00 for ODDITY Tech. ODDITY Tech earned $0.56 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.00 and a 52-week-low of $45.66. ODDITY Tech closed at $46.35 at the end of the last trading period.
